Observational studyScientific reports2026
Increased prevalence of hearing loss and tinnitus in patients with retinal vein occlusion.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging evidence suggests that sensorineural hearing loss and tinnitus may share similar microvascular and cardiometabolic etiologies, yet the potential association between retinal vein occlusion (RVO) and audiovestibular disorders has not been fully elucidated. This retrospective observational study aimed to investigate whether patients with RVO have an increased prevalence of tinnitus, hearing loss, vertigo, and sudden deafness. We used data from the Longitudinal Health Insurance Database 2010 of Taiwan. Adults diagnosed with RVO were identified and compared to comparison patients without RVO using a 1:3 propensity score matching approach, aligning them based on sociodemographic characteristics and vascular comorbidities. Multivariable logistic regressions were used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (CIs) of tinnitus, hearing loss, vertigo, and sudden deafness between RVO group and comparison group. A total of 6,403 patients with RVO and 19,209 matched compariosn patients were included. Compared with compariosn group, RVO group had significantly higher prevalence of tinnitus (13.90% vs. 11.58%; p<.001) and hearing loss (10.15% vs. 8.39%; p<.001), but not vertigo or sudden deafness. After adjustment, RVO remained associated with increased odds of tinnitus (OR = 1.236; 95% CI 1.136-1.344) and hearing loss (OR = 1.240; 95% CI 1.125-1.366). We concluded that RVO group exhibit a higher prevalence of tinnitus and hearing loss compared with matched comparison group, supporting a possible shared microvascular or systemic vascular pathophysiology. Audiologic assessment may be considered in the comprehensive evaluation of individuals with RVO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.